Le Lézard
Classified in: Health, Business
Subject: CXP

Sanford Health increases global presence with expansion in seven countries


SIOUX FALLS, South Dakota, Jan. 23, 2018 /PRNewswire/ -- Sanford Health is expanding its presence in international health care by extending services to seven countries. This year, Sanford Health will enter New Zealand, Ireland, Vietnam, Costa Rica and South Africa and increase its presence in China and Ghana. This expansion follows last year's acquisition of a minority stake in ISAR Klinikum, a hospital leader in stem cell therapies, located in Munich, Germany.

Sanford Health is one of the largest health care systems in the nation, with 44 hospitals and nearly 300 clinics in nine states and four countries. Headquartered in Sioux Falls, South Dakota, and serving the Upper Midwest of the United States, with nearly 1,400 physicians, Sanford Health is dedicated to several initiatives, including global children's clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. Sanford Health has 28,000 employees, making it the largest employer in the Dakotas.

Sanford Health's international health care arm, Sanford World Clinic, will now be in nine countries with more than 30 locations. Supported by philanthropy and launched in 2007, the initiative is designed to foster partnership with health care leaders in the development of sustainable services around the world.

"With these partnerships, we are creating unique opportunities for shared learning," said Kelby Krabbenhoft, president and CEO of Sanford Health. "This is not something we are pursuing for financial gain, but we believe this type of collaboration will help further our mission of health and healing."

Each partnership is unique in terms of scope of service and type of agreement. The focus of the collaborations range from primary and pediatric care to research and health system operations.

"We want to go where we can be impactful and create partnerships that will stand the test of time," said Dan Blue, M.D., executive vice president of Sanford World Clinic. "We have outstanding partners in each of these countries who share a common goal ? to advance health care around the world."

"We are excited about the oncology collaboration with Sanford Health and believe it could provide Chinese cancer patients with the most advanced treatment to improve the survival rate and the quality of life of patients," said Hu Bo, M.D., chairman of the board for Ciming Health Check Group and chairman of the healthcare management branch of the Chinese Medical Doctor Association.

Sanford World Clinic is working to identify three to five new partnerships each year.

To learn more about Sanford Health, visit www.sanfordhealth.org

To learn more about Omni Health, visit http://omnihealth.co.nz/

To learn more about Hermitage Medical Clinic, visit https://www.hermitageclinic.ie/

To learn more about Hospital Metropolitano, visit http://www.metropolitanocr.com/

To learn more about Victoria Healthcare, visit http://www.victoriavn.com/

To learn more about Stellenbosch University's Faculty of Medicine and Health Sciences, visit www.sun.ac.za

To learn more about Ciming Health Checkup Group, www.ciming.com

Contact:
Paul Heinert
Sanford Health Media Relations
605-366-2432 / [email protected] 

Logo - https://mma.prnewswire.com/media/631697/Sanford_Health_Header_Logo.jpg





These press releases may also interest you

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: